Gallbladder Polyps: Thresholds 6/10 mm and Indications for Cholecystectomy
Size Thresholds and Management Strategy
Size is the most important predictor of malignant transformation. Polyps ≥10 mm according to most guidelines (ACR, European guidelines) require cholecystectomy, whereas smaller lesions are managed with serial dynamic surveillance (typically follow-up at 6–12 months). According to EFSUMB data, malignant transformation of polyps 6–10 mm is extremely rare, while polyps >10 mm are considered preinvasive adenomas and papillary neoplasias. For polyps ≥2 cm, the risk of malignant transformation reaches 100%.
Important: the overall risk of gallbladder carcinoma in patients with polyps is low (0.053%). Many polyps demonstrate interval growth without necessarily increasing the risk of carcinoma.
Features Suggestive of True Neoplasia
| Feature | Significance |
|---|---|
| Size ≥10 mm | Indication for cholecystectomy (ACR, European guidelines) |
| Solitary lesion | Particularly in the absence of other signs of cholesterolosis |
| Growth on follow-up | Increase in size on surveillance imaging (follow-up at 6–12 months) |
| Vascularization on CDI/PD | Internal arterial blood flow—strong argument against a cholesterol polyp |
| Broad base / sessile type | Without prominent stalk; sessile polyp + wall thickening >4 mm—risk factor |
| Iso- or hypoechoic structure | Without hyperechoic inclusions and comet-tail artifact |
| Focal wall thickening / loss of stratification | Sign of malignant transformation |
Established Risk Factors for Gallbladder Carcinoma
According to the source, established risk factors include: large polyp (>1 cm), sessile polyp (in combination with wall thickening >4 mm), concurrent primary sclerosing cholangitis (PSC), Native American ethnicity, age >50 years. In the setting of PSC and gastrointestinal polyposis syndromes, up to 60% of gallbladder polyps are malignant.
Role of CEUS
Adenomas have a broader vascular pedicle, which is better visualized on CEUS. Polyps >10 mm with iso- and heterogeneous enhancement pattern may serve as a criterion for differentiating adenomas from cholesterol polyps. However, it remains unclear whether CEUS can reliably distinguish between polyps, adenomas, and non-invasive carcinoma.
Technical equipment limitations and scanning angle may yield false-negative results in small lesions.
Frequently asked questions
At what polyp size is cholecystectomy indicated?
At size ≥10 mm, most guidelines (ACR, European guidelines) recommend cholecystectomy; polyps >10 mm are regarded as preinvasive adenomas and papillary neoplasias.
What is the management strategy for polyps 6–10 mm?
Malignant transformation of polyps 6–10 mm is extremely rare; therefore, serial dynamic surveillance is applied, typically with follow-up at 6–12 months.
What ultrasound features suggest true neoplasia?
Solitary lesion, growth on follow-up, internal arterial blood flow on CDI/PD, broad base (sessile type), iso- or hypoechoic structure without comet-tail artifact, focal wall thickening.
What is the overall risk of carcinoma in polyps?
The overall risk of gallbladder carcinoma in patients with polyps is low—0.053%. For polyps ≥2 cm, the risk of malignant transformation reaches 100%.
What factors increase the risk of true neoplasia?
Large polyp (>1 cm), sessile polyp with wall thickening >4 mm, concurrent PSC, age >50 years, Native American ethnicity; in PSC and polyposis syndromes, up to 60% of polyps are malignant.